Our results showed increased GCL activity (Figure 3J) and GCLc protein levels (Figure 3K) in T2D-PDT PBMCs compared to controls (p < 0.05), suggesting a compensatory mechanism to restore GSH levels when comorbidity is present. Here, GCLC is linked to type 2 diabetes mellitus.